Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
- 1 February 2007
- journal article
- research article
- Published by Elsevier BV in Molecular Cell
- Vol. 25 (3), 473-481
- https://doi.org/10.1016/j.molcel.2007.01.017
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The epigenetic magic of histone lysine methylationThe FEBS Journal, 2006
- Combined DNA Methyltransferase and Histone Deacetylase Inhibition in the Treatment of Myeloid NeoplasmsCancer Research, 2006
- Histone Lysine Demethylases and Their Impact on EpigeneticsCell, 2006
- Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?Nature Reviews Cancer, 2006
- G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesisNature, 2006
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- Small Molecule Regulators of Protein Arginine MethyltransferasesPublished by Elsevier BV ,2004
- Nuclear transplantation, embryonic stem cells and the potential for cell therapyThe Hematology Journal, 2004
- mAM Facilitates Conversion by ESET of Dimethyl to Trimethyl Lysine 9 of Histone H3 to Cause Transcriptional RepressionMolecular Cell, 2003
- Role of Histone Methyltransferase G9a in CpG Methylation of the Prader-Willi Syndrome Imprinting CenterPublished by Elsevier BV ,2003